Related Experiment Video
Updated: Jul 10, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Giant cell myocarditis treated with long-term multi-modal care with multiple mechanical circulatory support: case
Motohiro Shingu1, Nishikawa Tatsuya1, Yuya Oga1
1Department of Cardiovascular Medicine, Akashi Medical Center, 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan.
Abstract:
We report the case of a 71-year-old woman with giant cell myocarditis presenting as acute heart failure and cardiogenic shock (LVEF 15%). She required mechanical ventilation, IMPELLA CP (Abiomed, Danvers, MA), veno-arterial extracorporeal (VA-ECMO), and continuous renal replacement therapy. Endomyocardial biopsy confirmed giant cell myocarditis, and treatment with corticosteroids, mycophenolate mofetil, and tacrolimus was initiated. Following multi-modal support and immunosuppressive therapy, left ventricular function recovered to 54%, allowing withdrawal of mechanical circulatory support and hemodialysis. However, the patient ultimately died on the 111th day due to the long treatment of cytomegalovirus infection and septic shock from catheter-related blood stream infection. Optimal immunosuppressive regimens remain undefined, so this case highlights successful recovery of cardiac function with intensive multi-modal management.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
